Nimotuzumab PowerPoint PPT Presentations

All Time
Show:
Recommended
Sort by:
Phase I study of nimotuzumab, a humanized anti-epidermal PowerPoint PPT Presentation
Phase I study of nimotuzumab, a humanized anti-epidermal - Phase I study of nimotuzumab, a humanized anti-epidermal growth factor receptor (EGFR) IgG1 monoclonal antibody in Japanese patients with solid tumors
Phase I study of nimotuzumab, a humanized anti-epidermal growth factor receptor (EGFR) IgG1 monoclonal antibody in Japanese patients with solid tumors
| PowerPoint PPT presentation | free to download
Diapositiva 1 PowerPoint PPT Presentation
Diapositiva 1 - Safety Nimotuzumab and radiotherapy in children and adolescents with brain stem glioma: Preliminary results from a Phase II study. C M T. Crombet1, R. Cabanas2, J ...
Safety Nimotuzumab and radiotherapy in children and adolescents with brain stem glioma: Preliminary results from a Phase II study. C M T. Crombet1, R. Cabanas2, J ...
| PowerPoint PPT presentation | free to download
India immune oncology drugs market analysis | Coherent Market Insights PowerPoint PPT Presentation
India immune oncology drugs market analysis | Coherent Market Insights - Read here the latest updates on the India immune-oncology drugs market analysis published by the CMI team.
Read here the latest updates on the India immune-oncology drugs market analysis published by the CMI team.
| PowerPoint PPT presentation | free to download
Diapositiva 1 PowerPoint PPT Presentation
Diapositiva 1 - CENTRO DE INMUNOLOG A MOLECULAR (CIM) LA HABANA, CUBA MSc. Yodira P rez D az QU ES EL CIM? Organizaci n Cubana de Inv, Des, Prod Inaugurado en Diciembre 1994.
CENTRO DE INMUNOLOG A MOLECULAR (CIM) LA HABANA, CUBA MSc. Yodira P rez D az QU ES EL CIM? Organizaci n Cubana de Inv, Des, Prod Inaugurado en Diciembre 1994.
| PowerPoint PPT presentation | free to download
Recent Developments in Oncology PowerPoint PPT Presentation
Recent Developments in Oncology - Targeted Therapy The first molecular target for targeted cancer therapy was the cellular receptor for the female sex hormone estrogen, ...
Targeted Therapy The first molecular target for targeted cancer therapy was the cellular receptor for the female sex hormone estrogen, ...
| PowerPoint PPT presentation | free to view


Home About Us Terms and Conditions Privacy Policy Contact Us
Copyright 2024 CrystalGraphics, Inc. — All rights Reserved. PowerShow.com is a trademark of CrystalGraphics, Inc.
nimotuzumab — Search results on PowerShow.com